Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer. - Wikidata - awgldk - TriplyDB

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

http://www.wikidata.org/entity/Q33563815

about

Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells Targeting Cdc20 as a novel cancer therapeutic strategy.Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells.Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.Anti-cancer activity of withaferin A in B-cell lymphoma.Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis Withania somnifera: From prevention to treatment of cancer Pharmacologic overview of Withania somnifera, the Indian Ginseng.ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.Withaferin-A Reduces Acetaminophen-Induced Liver Injury in Mice.Molecular insights into cancer therapeutic effects of the dietary medicinal phytochemical withaferin A.Synergistic antileukemic therapies in NOTCH1-induced T-ALL.The β-glucan from Lentinus edodes suppresses cell proliferation and promotes apoptosis in estrogen receptor positive breast cancers.Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice.Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms.

P2860

Q26766956-E443D86B-3B62-4368-BE47-A8F2800FA855 Q33755446-166F98C8-4248-4BFA-8EFA-67D6D8265E70 Q35688708-6C7C7EB2-10D8-4DB3-95FD-926B5E974C7A Q35729592-74D879F1-985D-4D5E-929D-DF1176F534D0 Q35870622-6182C11E-2760-48A6-9BD6-5311C6E888EF Q36213500-C5E51C36-2ACB-4294-B3A8-ACEC3008B811 Q36379354-104AC8D8-6EF0-429A-BD21-403645F9692E Q36984280-5257302E-246A-48C2-9F2D-947D59BAD1A0 Q38573788-399E05B3-4687-4B63-8D41-F37877369DE3 Q38684517-89F22CBA-DE31-4804-913E-4F72BFDB1516 Q38849089-52E2E3D9-A23A-4CB2-9628-A670F8E7D18A Q39120175-A6964F63-4682-4EA8-92AB-3BC867BE0B0E Q42051272-DA5C0E21-55B9-46D0-8DAE-55E151B0AB08 Q45770844-1CFCC95D-1248-4667-9474-A2CBC785C113 Q47257511-2BDC26C6-17EE-4E55-8713-2DE0B7FEEF41 Q47260584-DE8B09E6-F34C-4668-9D88-6FD7E554460A

P2860

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

http://www.wikidata.org/entity/Q33563815

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@ast

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@en

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@nl

type

label

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@ast

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@en

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@nl

prefLabel

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@ast

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@en

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@nl

P1433

Q33563815-C4E26DE2-D8A7-4A5B-B00D-ACA869EAE3A8

P1476

Q33563815-825BCFCD-DD30-4169-B664-4A2F96CA7590

P2093

Q33563815-53208CC9-7E00-485A-8B27-690D7B7DC390

Q33563815-7E5C56CE-636F-4E0D-996F-9A64D25334CB

Q33563815-94C1034F-5070-48DF-8082-283D3E37387F

Q33563815-F9EB21A7-C394-41D5-8005-B30DDCCE2C1C

P2860

Q33563815-02FF10F5-285A-4B04-A07A-5149DFDC99B3

Q33563815-0ACDD878-BFCE-42AB-8A62-434C4A1B16F9

Q33563815-10D72C41-00C0-4058-994F-7702384696D6

Q33563815-113004FA-0DF0-4135-B3DA-1BDF00735BC2

Q33563815-13F34ECB-146C-4717-A884-96C3AA0A28F1

Q33563815-14FF6A93-BE88-4C59-8728-DD2F29C21FE8

Q33563815-1D24DBD7-0224-45FF-BB28-C9183359B9D4

Q33563815-2C700502-BC84-413F-B37B-45E60957E199

Q33563815-41196068-8CF8-4249-9BA0-B10C15D1B3FA

Q33563815-47959F65-BE0D-485C-8FAD-FFD7EC2C1F3D

P304

Q33563815-65D5A358-7682-47BB-9B1C-063B16C26C64

P31

Q33563815-376018AF-4DD6-4F1B-8BCB-5CEA57CEB5DF

P356

Q33563815-26F1D9D2-4B4A-40DC-B168-64A9DDF13854

P407

Q33563815-9103DBFF-4195-4656-BA59-6C12B501BCD7

P433

Q33563815-FBF80859-DF2F-49F9-A12B-CA84D5FD0ADB

P478

Q33563815-EBC24FE0-24CF-4759-A8DD-534E6B4D40F9

P50

Q33563815-AA097CD5-AAEB-4E4B-AB02-2718144452F6

P577

Q33563815-49EA6C9E-1BF3-4FAC-A33D-DF40B33644E2

P698

Q33563815-642BA7FF-FB76-4221-BEED-74ED4E9D864A

P932

Q33563815-B176F131-816F-442A-8EF4-3C1AD33CB43F

P356

0008-5472.CAN-13-2081

P1433

Cancer Research

P1476

Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

@en

P2093

Arumugam Nagalingam

http://www.w3.org/2001/XMLSchema#string

Dipali Sharma

http://www.w3.org/2001/XMLSchema#string

Neeraj K Saxena

http://www.w3.org/2001/XMLSchema#string

Shivendra V Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling

RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer

Roles of CHOP/GADD153 in endoplasmic reticulum stress

Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo.

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis

leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3

ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation

A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis

Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.

Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A

P304

2617-2629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-13-2081

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Panjamurthy Kuppusamy

P577

2014-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24732433

http://www.w3.org/2001/XMLSchema#string

P932

4009451

http://www.w3.org/2001/XMLSchema#string